BRL 34915 (cromakalim) enhances voltage-dependent K+ current in cultured rat hippocampal neurons

Dora M T Politi, Setsuo Suzuki, Michael A Rogawski

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The whole cell voltage-clamp recording technique was used to study the effects of the benzopyran antihypertensive agent BRL 34915 on voltage-dependent outward currents in cultured rat hippocampal neurons. Extracellular perfusion with BRL 34915 (10-500 μM) produced a dose-dependent increase in the sustained (minimally inactivating) voltage-dependent outward altering the transient outward current (IA) or producing a change in the resting current at -60 mV. One-half maximal facilitation of the sustained outward current occured at 40 μM and maximal facilitation (59%) at 100 μM. The increase in outward current occurred at all potentials where hippocampal neurons exhibited outward rectification (> -30 mV). The effect of BRL 34915 was slow to develop (requiring as long as 5-15 min to achieve maximal effect) and persisted for at least 10-15 min after cessation of the drug superfusion. Like the sustained outward current recorded under control conditions, the outward current augmented by BRL 34915 wasinhibited by the K+ channel blocker tetraethylammonium (20 mM). These results indicate that BRL 34915 can enhance the activity of sustained voltage-dependent K+ channels in mammalian CNS neurons.

Original languageEnglish (US)
Pages (from-to)7-14
Number of pages8
JournalEuropean Journal of Pharmacology
Volume168
Issue number1
DOIs
StatePublished - Sep 1 1989
Externally publishedYes

Fingerprint

Cromakalim
Neurons
Benzopyrans
Tetraethylammonium
Patch-Clamp Techniques
Antihypertensive Agents
Perfusion
Pharmaceutical Preparations

Keywords

  • (Whole cell patch clamp)
  • Cromakalim (BRL 34915)
  • Hippocampus
  • K channels
  • Tetraethylammonium

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

BRL 34915 (cromakalim) enhances voltage-dependent K+ current in cultured rat hippocampal neurons. / Politi, Dora M T; Suzuki, Setsuo; Rogawski, Michael A.

In: European Journal of Pharmacology, Vol. 168, No. 1, 01.09.1989, p. 7-14.

Research output: Contribution to journalArticle

@article{5d2af8af69ef4515b4e9d63be67fcc8c,
title = "BRL 34915 (cromakalim) enhances voltage-dependent K+ current in cultured rat hippocampal neurons",
abstract = "The whole cell voltage-clamp recording technique was used to study the effects of the benzopyran antihypertensive agent BRL 34915 on voltage-dependent outward currents in cultured rat hippocampal neurons. Extracellular perfusion with BRL 34915 (10-500 μM) produced a dose-dependent increase in the sustained (minimally inactivating) voltage-dependent outward altering the transient outward current (IA) or producing a change in the resting current at -60 mV. One-half maximal facilitation of the sustained outward current occured at 40 μM and maximal facilitation (59{\%}) at 100 μM. The increase in outward current occurred at all potentials where hippocampal neurons exhibited outward rectification (> -30 mV). The effect of BRL 34915 was slow to develop (requiring as long as 5-15 min to achieve maximal effect) and persisted for at least 10-15 min after cessation of the drug superfusion. Like the sustained outward current recorded under control conditions, the outward current augmented by BRL 34915 wasinhibited by the K+ channel blocker tetraethylammonium (20 mM). These results indicate that BRL 34915 can enhance the activity of sustained voltage-dependent K+ channels in mammalian CNS neurons.",
keywords = "(Whole cell patch clamp), Cromakalim (BRL 34915), Hippocampus, K channels, Tetraethylammonium",
author = "Politi, {Dora M T} and Setsuo Suzuki and Rogawski, {Michael A}",
year = "1989",
month = "9",
day = "1",
doi = "10.1016/0014-2999(89)90626-2",
language = "English (US)",
volume = "168",
pages = "7--14",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - BRL 34915 (cromakalim) enhances voltage-dependent K+ current in cultured rat hippocampal neurons

AU - Politi, Dora M T

AU - Suzuki, Setsuo

AU - Rogawski, Michael A

PY - 1989/9/1

Y1 - 1989/9/1

N2 - The whole cell voltage-clamp recording technique was used to study the effects of the benzopyran antihypertensive agent BRL 34915 on voltage-dependent outward currents in cultured rat hippocampal neurons. Extracellular perfusion with BRL 34915 (10-500 μM) produced a dose-dependent increase in the sustained (minimally inactivating) voltage-dependent outward altering the transient outward current (IA) or producing a change in the resting current at -60 mV. One-half maximal facilitation of the sustained outward current occured at 40 μM and maximal facilitation (59%) at 100 μM. The increase in outward current occurred at all potentials where hippocampal neurons exhibited outward rectification (> -30 mV). The effect of BRL 34915 was slow to develop (requiring as long as 5-15 min to achieve maximal effect) and persisted for at least 10-15 min after cessation of the drug superfusion. Like the sustained outward current recorded under control conditions, the outward current augmented by BRL 34915 wasinhibited by the K+ channel blocker tetraethylammonium (20 mM). These results indicate that BRL 34915 can enhance the activity of sustained voltage-dependent K+ channels in mammalian CNS neurons.

AB - The whole cell voltage-clamp recording technique was used to study the effects of the benzopyran antihypertensive agent BRL 34915 on voltage-dependent outward currents in cultured rat hippocampal neurons. Extracellular perfusion with BRL 34915 (10-500 μM) produced a dose-dependent increase in the sustained (minimally inactivating) voltage-dependent outward altering the transient outward current (IA) or producing a change in the resting current at -60 mV. One-half maximal facilitation of the sustained outward current occured at 40 μM and maximal facilitation (59%) at 100 μM. The increase in outward current occurred at all potentials where hippocampal neurons exhibited outward rectification (> -30 mV). The effect of BRL 34915 was slow to develop (requiring as long as 5-15 min to achieve maximal effect) and persisted for at least 10-15 min after cessation of the drug superfusion. Like the sustained outward current recorded under control conditions, the outward current augmented by BRL 34915 wasinhibited by the K+ channel blocker tetraethylammonium (20 mM). These results indicate that BRL 34915 can enhance the activity of sustained voltage-dependent K+ channels in mammalian CNS neurons.

KW - (Whole cell patch clamp)

KW - Cromakalim (BRL 34915)

KW - Hippocampus

KW - K channels

KW - Tetraethylammonium

UR - http://www.scopus.com/inward/record.url?scp=0024428125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024428125&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(89)90626-2

DO - 10.1016/0014-2999(89)90626-2

M3 - Article

C2 - 2583232

AN - SCOPUS:0024428125

VL - 168

SP - 7

EP - 14

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -